The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study
Open accessAbstract
One hundred twenty-six patients with cirrhosis, hyperammonemia (>50 μmol/L), and chronic (persistent) hepatic encephalopathy (HE), which developed spontaneously without the existence of known precipitating factors, were enrolled in a randomized, double-blind, placebo-controlled clinical trial of intravenously administered L- ornithine-L-aspartate (OA). Patients with subclinical (grade 0, West- Haven criteria) hepatic encephalopathy (SHE), characterized by a prolonged number connection test A (NCT-A) time, and manifest HE (grades I and II, West-Haven criteria) were included in the investigation. The trial was planned as a confirmatory clinical trial OA administered in a dose of 20 g/d, as well as placebo, were dissolved in 250 mL of 5% fructose and infused intravenously for a period of 4 hours during 7 consecutive days with a superimposed protein load at the end of the daily treatment period. Primary variables were postprandial venous ammonia and NCT-A performance time measured following OA or placebo infusions to evaluate the net effect of the treatment on the prevention of the protein-induced hyperammonemia, and on parameters such as NCT-A influenced by hyperammonemia. Mental state gradation, portal systemic encephalopathy index (PSEI), and fasting ammonia levels were estimated as additional efficacy parameters. The data presented are based on the total study sample (intent-to-treat analysis), which included 63 patients in the placebo group and 63 patients in the OA group. Of the 126 patients, 114 met all the criteria for inclusion and completed the trial and treatment as outlined in the protocol (treated- per-protocol analysis). During baseline, the placebo and treatment groups were homogeneous with regard to mental states, NCT-A performance time, fasting venous blood ammonia levels, and Child-Pugh criteria. Although a slight improvement occurred in the placebo group, NCT-A performance times (P < .001) and postprandial venous ammonia concentrations in the OA-treated group showed improvements in comparison with placebo. In addition, venous fasting blood ammonia concentration (P < .01), mental state gradation (P < .001), and PSEI (P < .01), which includes the mental state gradation, NCT-A time, and postprandial venous ammonia in this trial, improved to a much higher degree in the OA group than in the placebo group. In subgroups retrospectively classified according to their initial mental state gradation, OA showed differential but uniformly significant efficacies in patients with manifest HE with respect to ammonia-lowering, improvement in NCT times, and mental state gradation. In patients with initial SHE, OA revealed differences between the medications in the psychometric test used. Adverse events consisting of mild gastrointestinal disturbances were observed in 3 of the OA-treated patients (5%). OA infusion appears to be a safe, effective treatment of chronic (persistent) manifest HE in cirrhotic patients. Additional investigations are required to assess the efficacy of OA in patients with SHE, as well as in patients with more severe grades of HE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Compensated cirrhosis: Natural history and prognostic factors
Ginés, P., Quintero, E., Arroyo, V., Terés, J., Bruguera, M., Rimola, A., Caballería, J., Rodés, J., & Rozman, C. (1987) · Hepatology · doi:10.1002/hep.1840070124 · Cited by 1,106
The Continuing Unethical Use of Placebo Controls
Rothman, K. J., & Michels, K. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310611 · Cited by 663
Häussinger, D., Laubenberger, J., Vom Dahl, S., Ernst, T., Bayer, S., Langer, M., Gerok, W., & Hennig, J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90552-5 · Cited by 415
Gebhardt, R., & Mecke, D. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01464.x · Cited by 377
HÄUSSINGER, D. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07458.x · Cited by 297
The Hepatic Coma Syndromes and Lactulose
Conn, H. O., Lieberthal, M. M., & Mandell, H. N. (1980) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198006000-00023 · Cited by 296
Atterbury, C. E., Maddrey, W. C., & Conn, H. O. (1978) · The American Journal of Digestive Diseases · doi:10.1007/bf01072921 · Cited by 263
Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats
Takahashi, H., Koehler, R. C., Brusilow, S. W., & Traystman, R. J. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.261.3.h825 · Cited by 262
Placebo effect in double-blind clinical trials: a review of interactions with medications
Kleijnen, J., de Craen, A. J. M., van Everdingen, J., & Krol, L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90699-8 · Cited by 189
Cited by
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K. D., Weissenborn, K., & Wong, P. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,056
Felipo, V., & Butterworth, R. F. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00019-9 · Cited by 618
Blei, A. T., & Córdoba, J. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03964.x · Cited by 527
Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials
Als-Nielsen, B., Gluud, L. L., & Gluud, C. (2004) · BMJ · doi:10.1136/bmj.38048.506134.ee · Cited by 371
Metadata
- Authors
- Kircheis, G., Nilius, R., Held, C., Berndt, H., Buchner, M., Gortelmeyer, R., Hendricks, R., Kruger, B., Kuklinski, B., Meister, H., Otto, H., Rink, C., Rosch, W., & Stauch, S.
- Venue
- Hepatology
- Published
- 1997-06
- Volume
- 25
- Issue
- 6
- Pages
- 1351-1360
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1990773808
- Cited by
- 318
- References
- 29
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study. https://app.cochat.ai/papers/10.1002/hep.510250609
- The paper
- Kircheis, G., Nilius, R., Held, C., Berndt, H., Buchner, M., Gortelmeyer, R., Hendricks, R., Kruger, B., Kuklinski, B., Meister, H., Otto, H., Rink, C., Rosch, W., & Stauch, S. (1997). Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study. Hepatology. https://doi.org/10.1002/hep.510250609
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.